PPH Holdings — VanEck Pharmaceutical ETF
All 26 reported holdings of VanEck Pharmaceutical ETF (PPH) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 20.23% | $177.92M |
| Novartis AG | 10.63% | $93.44M |
| Merck & Co Inc | 9.85% | $86.58M |
| Novo Nordisk A/S | 5.37% | $47.19M |
| AbbVie Inc | 4.57% | $40.23M |
| Pfizer Inc | 4.51% | $39.64M |
| Bristol-Myers Squibb Co | 4.47% | $39.30M |
| Gsk PLC | 4.42% | $38.85M |
| Johnson & Johnson | 4.35% | $38.30M |
| AstraZeneca PLC | 4.33% | $38.11M |
| McKesson Corp | 4.12% | $36.25M |
| Sanofi SA | 4.00% | $35.21M |
| Cencora Inc | 3.36% | $29.51M |
| Haleon PLC | 3.09% | $27.18M |
| Teva Pharmaceutical Industries Ltd | 3.06% | $26.89M |
| Takeda Pharmaceutical Co Ltd | 2.87% | $25.26M |
| Zoetis Inc | 2.10% | $18.46M |
| Viatris Inc | 1.09% | $9.63M |
| Jazz Pharmaceuticals PLC | 1.08% | $9.50M |
| Axsome Therapeutics Inc | 0.77% | $6.75M |
| Corcept Therapeutics Inc | 0.50% | $4.43M |
| Elanco Animal Health Inc | 0.35% | $3.11M |
| State Street Global Advisors | 0.28% | $2.43M |
| Organon & Co | 0.23% | $2.01M |
| Bausch Health Cos Inc | 0.10% | $860.86K |
| Perrigo Co PLC | 0.06% | $528.46K |